Plasma renin substrate, a widely measured parameter of the renin reaction, is quantitated indirectly by the measurement of liberated angiotensin I upon exhaustive incubation of plasma with added renin. To overcome methodological problems of this assay system, we have developed a direct radioimmunoassay for this plasma protein using renin substrate purified from pooled plasma of normotensive subjects as the antigen. Comparison of substrate quantitated by the two assay systems (direct and indirect) indicates a 1:1 correlation with the exception of certain subjects with elevated substrate levels induced by estrogen therapy. To study the possibility of multiple substrate forms, we have made a comparison of substrate quantitated by both radioimmunoassays in conjunction with electrophoresis of plasma on polyacrylamide gel. One major form of substrate with a retardation factor (R f ) = 0.60 was found in normotensive and essential hypertensive subjects which gave a 1:1 correspondence on quantitation by the two methods. In contrast, six of 16 women on oral contraceptives demonstrated three forms of substrate (Rf = 0.16, 0.35, and 0.60) on electrophoresis. Substrate with R r = 0.16 and 0.35 did not cross-react with the antiserum prepared against substrate from normotensive subjects, implying structural differences in these proteins.
SUMMARY Plasma renin substrate, a widely measured parameter of the renin reaction, is quantitated indirectly by the measurement of liberated angiotensin I upon exhaustive incubation of plasma with added renin. To overcome methodological problems of this assay system, we have developed a direct radioimmunoassay for this plasma protein using renin substrate purified from pooled plasma of normotensive subjects as the antigen. Comparison of substrate quantitated by the two assay systems (direct and indirect) indicates a 1:1 correlation with the exception of certain subjects with elevated substrate levels induced by estrogen therapy. To study the possibility of multiple substrate forms, we have made a comparison of substrate quantitated by both radioimmunoassays in conjunction with electrophoresis of plasma on polyacrylamide gel. One major form of substrate with a retardation factor (R f ) = 0.60 was found in normotensive and essential hypertensive subjects which gave a 1:1 correspondence on quantitation by the two methods. In contrast, six of 16 women on oral contraceptives demonstrated three forms of substrate (Rf = 0.16, 0.35, and 0.60) on electrophoresis. Substrate with R r = 0.16 and 0.35 did not cross-react with the antiserum prepared against substrate from normotensive subjects, implying structural differences in these proteins.
THE CURRENTLY employed method for renin substrate quantitation is indirect since it measures not the substrate itself, but its capacity to generate angiotensin I (A I) in the presence of excess renin. 1 ' 2 This procedure suffers from several inherent problems including the requirement of partially purified, preferably homologous renin, the adjustment of incubation times to assure complete consumption of substrate, and protection of the generated A I from degradation by angiotensinases. The wide range of plasma renin substrate concentrations and the occasional differences in angiotensinase activity of individual plasma samples make it difficult to find a single set of incubation conditions appropriate for all samples. In view of these considerations, we have developed a direct radioimmunoassay for renin substrate using human renin substrate purified from normal human plasma as the antigen. 3 Using polyacrylamide gel electrophoresis and an antiserum generated against human renin substrate, we have studied the possibility of multiple substrate types in normal and hypertensive subjects, particularly in states of stimulated substrate synthesis (estrogen therapy and pregnancy). It has been well-established that oral contraceptive therapy induces elevated levels of plasma renin substrate. 4 "" 6 The mechanism of this increase in man is not known but could involve either increased synthesis of normal renin substrate or generation of different forms of substrate. Menard et al. 7 have shown that, in the rat, binephrectomy or estrogens induce significant increases in the plasma renin substrate levels without alterations in the protein's molecular size, isoelectric point, or electrophoretic mobility in polyacrylamide gel at pH 7.8 or 10. 2. Skeggs et al. 8 have reported multiple forms of renin substrate in pooled hog plasma; these proteins were essentially homologous with respect to amino acid composition and molecular weight, differing only in the carbohydrate moiety. We have recently reported the isolation and purification of human renin substrate from pooled plasma of normotensive subjects; 1 only one form of renin substrate was evident, but minor components may well have been overlooked by the purification methodology employed. The possibility of multiple forms in certain normotensive individuals, patients with hypertension, or under conditions of increased renin substrate synthesis were not ruled out. Using polyacrylamide gel electrophoresis and crossreactivity with the newly developed antiserum, we have developed evidence for heterogeneity of human renin substrate .
Methods

RENIN SUBSTRATE
Human renin substrate was isolated and purified from the plasma of normotensive subjects by the recently described method of Eggena et al. 3 This procedure included ammonium-suifate precipitation, chromatography on Sephadex G150, DEAE-cellulose, and calcium phosphate gel followed by isoelectric focusing and preparative polyacrylamide gel electrophoresis.
ANTISERUM
Renin substrate, purified through the calcium phosphate gel chromatographic step, was used as an antigen.
Antiserum was prepared by subcutaneous injection into New Zealand white rabbits with complete Freund's adjuvant (CalBiochem). Immunization was repeated six times at 2-week intervals. Animals were bled by cardiac puncture 3-5 days after the last immunization. Antiserum was divided into 1-ml fractions, frozen in dry ice-alcohol bath, and stored at -40°C.
RADIOIMMUNOASSAY FOR SUBSTRATE
Direct
Plasma (0.25 v-V) was pipetted directly into Beckman biovials containing 0.2 ml of 0.1 M Tris-acetate buffer, pH 7.4. A freshly prepared mixture (0.8 ml) of antiserum (1:30,000 dilution) and 0.1% lysozyme (Sigma) in the above buffer was added. This mixture also contained sufficient 125 I-labeled, completely purified, human renin substrate, 3 iodinated by the method of Hunter and Greenwood, 9 to ensure at least 5,000 counts/min per tube. Samples were equilibrated for 24-36 hours at 4°C, and antibody-bound and free substrate were separated by the addition of a second antibody (goat anti-rabbit -globulin). No special precautions were taken to inhibit the action of renin, since cross-reactivity with des-angiotensin renin substrate was high. Free labeled substrate (0.5 ml of supernatant fluid) was taken from each tube and counted in a Beckman Biogamma spectrometer.
Indirect
Substrate was quantitated by the amount of angiotensin generated upon incubation for 3 hours at 37°C in the presence of excess renin followed by a radioimmunoassay for A I according to the method of Eggena et al. 1 
ELECTROPHORETIC SEPARATION OF SUBSTRATE TYPES
Polyacrylamide gel electrophoresis of plasma samples (0.1 ml) was performed at pH 8.3 in a 7% gel. 10 Gels were sliced in 2-mm sections and eluted with 0.55 ml of 0.15 M Tris-acetate buffer, pH 7.4, in a Gilson Aliquogel fractionator (B-100/GMA-GCB). Renin substrate was determined in each fraction by both radioimmunoassay techniques.
Results
DIRECT RADIOIMMUNOASSAY FOR RENIN SUBSTRATE
The administration of purified human renin substrate led to the production of antibody in all three animals. Titers varied from 1:10,000 to 1:50,000 (capacity to bind 50% of 5,000 counts/min I25 I-labeled renin substrate). A typical standard curve and a log-logit transformation of the data are shown in Figure 1 . The effective range of this assay is from 5 to 150 ng of renin substrate (58-1,750 pg A I equivalents using a molecular weight of 110,000). For the generation of a standard curve, both purified renin substrate and a plasma sample that was quantitated by the indirect method were compared. Both preparations gave rise to equivalent standard curves. The substrate antiserum cross-reacted with neither A I nor the synthetic tetra- decapeptide substrate; it did, however, cross-react (90%) with the other cleavage product of the renin reaction, desangiotensin I renin substrate. Substrate concentration determined by direct assay after incubation with excess added renin showed only a 10% reduction in substrate concentration after incubation. We have shown des-angiotensin substrate to be present in significant quantities in plasma after incubation with added renin."
COMPARISON OF DIRECT AND INDIRECT RADIOIMMUNOASSAYS
Comparison of the results obtained with the direct and indirect radioimmunoassays for renin substrate are shown in Figure 2 
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RENIN-SUBSTRATE REACTION SUPP. II, CIRC. RES. VOL. 41, No. 4, OCTOBER 1977 l.lx +35.7, r = 0.7, P < 0.01, demonstrates a 1:1 correspondence and a good correlation of the results of the two assay systems for normotensives (« = 15), essential hypertensives (n = 30), and 10 of 16 women on oral contraceptive therapy (group I). It is noteworthy that certain women on oral contraceptives, n = 6 (group II), as shown in Figure 2 , demonstrate significantly greater renin substrate values as measured by the indirect assay group 1:1,000-7,000; group II: 7,000-13,000 ng A I equivalent per ml plasma, P < 0.005).
HETEROGENEITY OF RENIN SUBSTRATE
Plasma from normal subjects, essential hypertension patients, and women on oral contraceptive therapy was fractionated by polyacrylamide gel electrophoresis at pH 8.4 to investigate whether heterogeneity in renin substrate could account for the differences between direct and indirect assay methods for the quantitation of substrate of group I and II subjects. Upon incubation of the homogenized gel slices with added homologous renin, plasma from group II subjects (n = 6) showed three major peaks of substrate activity (Fig. 3a) . Direct assay of the same gel fractions revealed only one peak of renin substrate, corresponding to the peak with the greatest anodic electrophoretic mobility (R f = 0.60) detected by the indirect assay. The absolute quantity of substrate in the three peaks, as measured by generated angiotensin, was variable, but the minimum quantity of each peak was always in excess of 15% of the total substrate. In contrast, group I subjects showed one major substrate peak on electrophoresis, R, = 0.60 ± 0.06 SD, which could be quantitated by either assay system (Fig. 3b ). Trace quantities (<1 %) of the other two (9) method of substrate quantitation. RF is defined as the ratio of the distance migrated toward anode by the substrate peak(s) with respect to albumin, b, Same as above for plasma from normal and essential hypertensive subjects.
forms of renin substrate R f 0.16 ± 0.02 SD and R f = 0.35 ± 0.05 SD were observed in several group I subjects.
All three substrate components were also evident in three additional women during the last trimester of pregnancy as shown for group II subjects in Fig. 3a . Another woman in her first trimester demonstrated only one peak, R f = 0.60, a pattern identical to that of group I subjects shown in Figure 3b .
Discussion
We have developed a direct radioimmunoassay for renin substrate in human plasma which, with the exception of group II subjects, gives results equivalent to those obtained with the conventional indirect method. The data of the standard curve (direct assay) can be linearized by the log-logit transformation, facilitating data analysis. This direct radioimmunoassay has several advantages over the conventional indirect assay: (1) a preparation of partially purified renin for the generation of A I is not required, (2) the difficult problem of suppressing angiotensinases 12 is avoided, and (3) the problem of complete conversion of substrate to A I upon incubation is circumvented.
The results of this study confirm our previous report 3 that normal human plasma contains one predominant form of renin substrate and extend this finding to the renin substrate of patients with essential hypertension. One form of renin substrate (R f = 0.60) was also found in a preliminary examination of a few patients with malignant and renovascular hypertension (n = 3). In contrast, those women on oral contraceptive therapy who have the highest substrate concentrations and demonstrate a lack of correlation between the two methods of quantitation have significant quantities of two other forms of renin substrate in their plasma. This observation also applies to the women in their third trimester of pregnancy (n = 3) when estrogen levels are elevated. Multiple forms of substrate were also observed in a male patient, treated with estrogen for cancer of the prostate gland. A woman in the first trimester, however, in which estrogen levels are not significantly elevated, showed only one major substrate component (R f = 0.60) equivalent to that of group I subjects (Fig. 3b) . The additional forms of substrate found in group II subjects are capable of generating A I when incubated with renin but are not recognized by the antiserum prepared against renin substrate from normotensive subjects and, therefore, are structurally different. The presence or absence of correlation in quantitation of renin substrate by both methods will allow us to screen large numbers of patients in our investigations of the possible physiopathological role of these additional forms of renin substrate.
At present we are in the process of isolating and purifying the two additional forms of renin substrate to determine their physical, chemical, and immunological characteristics. It also remains to be established whether the estrogen-induced increase of renin substrate is due to stimulation of the minor trace components seen in several of the normal and hypertensive subjects or represents the induction of structurally different forms.
Resolution of Multiple Forms of Human Angiotensinogen
Isoelectric Focusing Heterogeneity Profile Analysis ANGIOTENSINOGEN, the prohormone of the angiotensin peptides, is synthesized by the liver and secreted into the circulation 1 where it appears to serve as the protein substrate for the acid protease, renin (EC 3.4.99.19) . The result of this interaction, the decapeptide angiotensin I (A I), is further degraded by converting enzyme (EC 3.4.15.1, kininase II) 2 ' 3 to the octapeptide angiotensin II and, subsequently, by aminopeptidase activity to angiotensin III. 4 These two steps involve, first, the enzymatic removal of the two carboxyl-terminal amino From the Division of Pharmacology, Department of Medicine, University of California at San Diego, La Jolla, California.
Supported by National Institutes of Health Grant HL 15808. John A. Lewicki and Timothy Gregory are predoctoral Fellows in the Physiology-Pharmacology Graduate Program. acids of angiotensin I, histidine 9 and leucine 10 and, second, the cleavage of the amino-terminal aspartic acid. Angiotensin II functions in blood pressure homeostasis both by direct effects on vascular smooth muscle tone and indirectly via sodium and volume mechanisms. 5 ' 6 These actions may be expressed by either peripheral or central mechanisms. 7 -8 Because of the multiplicity of actions of angiotensin, attention continues to be focused on this hormonal system and its potential role in hypertensive diseases. 9
Few biochemical studies have been reported on angiotensinogen, in large measure due to difficulties in the isolation and purification of this serum protein. In normotensive human serum, the concentration of this protein is approximately 70 /ng/ml and its identification as an a-
